Announced
Completed
Synopsis
Novartis, a multinational pharmaceutical company, completed the acquisition of Chong Kun Dang Pharmaceutical, a pharmaceutical company, for 1.3bn. This is the largest-ever out-licensing deal for the Korean pharmaceutical company since its inception more than eight decades ago, as well as this year's largest Korean pharmaceutical industry deal.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.